Skip to content
← Back to this collection

PUBLICATIONS · 21282540

Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2011 Mar 10
First author
Palumbo A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Palumbo A
      type
      Author
    2. name
      Cavo M
      type
      Author
    3. name
      Bringhen S
      type
      Author
    4. name
      Zamagni E
      type
      Author
    5. name
      Romano A
      type
      Author
    6. name
      Patriarca F
      type
      Author
    7. name
      Rossi D
      type
      Author
    8. name
      Gentilini F
      type
      Author
    9. name
      Crippa C
      type
      Author
    10. name
      Galli M
      type
      Author
    11. name
      Nozzoli C
      type
      Author
    12. name
      Ria R
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Palumbo A
      type
      Author
    2. name
      Cavo M
      type
      Author
    3. name
      Bringhen S
      type
      Author
    4. name
      Zamagni E
      type
      Author
    5. name
      Romano A
      type
      Author
    6. name
      Patriarca F
      type
      Author
    7. name
      Rossi D
      type
      Author
    8. name
      Gentilini F
      type
      Author
    9. name
      Crippa C
      type
      Author
    10. name
      Galli M
      type
      Author
    11. name
      Nozzoli C
      type
      Author
    12. name
      Ria R
      type
      Author
    bibliography ids
    1. nci-bib-bae36031cea6df928bcb3192
    book metadata
    content sha256
    5e802a27f55f3c578dae5103d20609c4dea17d2bba68d493db9b2245d2f9cbe6
    document type
    citation
    dois
    1. 10.1200/JCO.2010.31.6844
    electronic publication date
    display
    2011 Jan 31
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21282540
    immutable id
    pubmed:21282540@5e802a27f55f3c578dae5103d20609c4dea17d2bba68d493db9b2245d2f9cbe6
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    8
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    986-93
    volume
    29
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21282540
      provenance
      batch id
      edef4b7f1a2a505cd5a9
      provider
      NCBI PubMed ESummary
      record sha256
      cbda10166889a135143e44df1e67f8b6300b9594c3f0e002f034666a1e57f488
      response sha256
      d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
      retrieved at
      2026-09-09T23:46:38.027615+00:00
      publication date
      display
      2011 Mar 10
      precision
      day
      year
      2011
      publication types
      1. Clinical Trial, Phase III
      2. Comparative Study
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21282540/
      title
      Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.

      Preserved source evidence · Not medical advice